chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Vaccination site pain
Clinical narrative: Felt uncomfortable while being administered the second injection and after getting it; Felt pain while being administered the second injection and after getting it; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Felt uncomfortable while being administered the second injection and after getting it) and VACCINATION SITE PAIN (Felt pain while being administered the second injection and after getting it) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Felt uncomfortable while being administered the second injection and after getting it) and VACCINATION SITE PAIN (Felt pain while being administered the second injection and after getting it). At the time of the report, DISCOMFORT (Felt uncomfortable while being administered the second injection and after getting it) and VACCINATION SITE PAIN (Felt pain while being administered the second injection and after getting it) outcome was unknown.            No concomitant medications were reported.  The patient did not feel anything while being administered the first injection.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-123076, US-MODERNATX, INC.-MOD-2021-123087 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123076:Case for mother US-MODERNATX, INC.-MOD-2021-123087:Case for wife
Sex: U
Vaccine: COVID19
Symptoms: Anosmia
Clinical narrative: lost sense of smell; This spontaneous case was reported by a health care professional and describes the occurrence of ANOSMIA (lost sense of smell) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (lost sense of smell). At the time of the report, ANOSMIA (lost sense of smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  No treatment information was provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Listless, Pain
Clinical narrative: Listless; Sore; Blah; Tired; This spontaneous case was reported by a consumer and describes the occurrence of LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031-A2419 and 006-M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FISH OIL and CHONDROITIN SULFATE, GLUCOSAMINE (GLUCOSAMINE CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE]) for an unknown indication.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired). On 10-May-2021, LISTLESS (Listless), PAIN (Sore), FEELING ABNORMAL (Blah) and FATIGUE (Tired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication were included high blood pressure medication, medication to treat high cholesterol, medication to treat "PSA" levels for prostate The treatment information was unknown.  Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-123330 (E2B Linked Report). This case was linked to MOD-2021-123068 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123330:Case for husband
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore shoulder where the injection was given; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore shoulder where the injection was given) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sinusitis (Sinus allergy.).    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PAIN (Sore shoulder where the injection was given). At the time of the report, VACCINATION SITE PAIN (Sore shoulder where the injection was given) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-122922 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Urinary tract infection
Clinical narrative: Has UTI infection; Reschedule her second Moderna COVID-29 vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (Has UTI infection) and PRODUCT DOSE OMISSION ISSUE (Reschedule her second Moderna COVID-29 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medication history was provided.  Concomitant products included CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) from 12-May-2021 to an unknown date for UTI.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Reschedule her second Moderna COVID-29 vaccine). On an unknown date, the patient experienced URINARY TRACT INFECTION (Has UTI infection). At the time of the report, URINARY TRACT INFECTION (Has UTI infection) had not resolved and PRODUCT DOSE OMISSION ISSUE (Reschedule her second Moderna COVID-29 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provider by the reporter.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Muscle spasms, Product dose omission issue, Vaccination site erythema, Vaccination site pain
Clinical narrative: Missed the appointment of Moderna COVID-19 vaccine/ missed the appointment for the second shot; Not feeling well; Redness from the shot; Felt like a baseball bat hit my shoulder/ I felt weird, a lot of pain; Shoulder was cramping up/ arm was cramping; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Shoulder was cramping up/ arm was cramping), PRODUCT DOSE OMISSION ISSUE (Missed the appointment of Moderna COVID-19 vaccine/ missed the appointment for the second shot), MALAISE (Not feeling well), VACCINATION SITE ERYTHEMA (Redness from the shot) and VACCINATION SITE PAIN (Felt like a baseball bat hit my shoulder/ I felt weird, a lot of pain) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced MUSCLE SPASMS (Shoulder was cramping up/ arm was cramping), VACCINATION SITE ERYTHEMA (Redness from the shot) and VACCINATION SITE PAIN (Felt like a baseball bat hit my shoulder/ I felt weird, a lot of pain). On 05-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the appointment of Moderna COVID-19 vaccine/ missed the appointment for the second shot) and MALAISE (Not feeling well). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 800 mg three times a day. At the time of the report, MUSCLE SPASMS (Shoulder was cramping up/ arm was cramping), MALAISE (Not feeling well), VACCINATION SITE ERYTHEMA (Redness from the shot) and VACCINATION SITE PAIN (Felt like a baseball bat hit my shoulder/ I felt weird, a lot of pain) had resolved and PRODUCT DOSE OMISSION ISSUE (Missed the appointment of Moderna COVID-19 vaccine/ missed the appointment for the second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications taken by the patient included multiple medications to treat Lupus.  Treatment activities included some pain medications.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient got first vaccine dose 78 days ago; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient got first vaccine dose 78 days ago) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient got first vaccine dose 78 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient got first vaccine dose 78 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Fine motor skill dysfunction, Muscular weakness
Clinical narrative: Hard time controlling fine motor movements; Arm is weaker; Fatigue easily; This spontaneous case was reported by a consumer and describes the occurrence of FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045B21A and 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily). At the time of the report, FINE MOTOR SKILL DYSFUNCTION (Hard time controlling fine motor movements), MUSCULAR WEAKNESS (Arm is weaker) and FATIGUE (Fatigue easily) outcome was unknown.            No concomitant medications were being used.  Treatment information was not reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: the patient had a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (the patient had a cold) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031-A2419) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included GLUCOSAMINE & CHONDORITIN for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced NASOPHARYNGITIS (the patient had a cold). On 03-May-2021, NASOPHARYNGITIS (the patient had a cold) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included high blood pressure medications, high cholesterol medications and medications to treat PSA levels of prostate and fish oil.  No treatment details were reported.     This case was linked to MOD-2021-122966, MOD-2021-122966 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site dysaesthesia, Vaccination site pain
Clinical narrative: uncomfortable while being administered the 2nd dose and after; Injection felt painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful). At the time of the report, VACCINATION SITE DYSAESTHESIA (uncomfortable while being administered the 2nd dose and after) and VACCINATION SITE PAIN (Injection felt painful) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-122933, US-MODERNATX, INC.-MOD-2021-123087 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-122933:wife US-MODERNATX, INC.-MOD-2021-123087:husband
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Vaccination site pain
Clinical narrative: more uncomfortable while getting the injection and after; Injection felt painful; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (more uncomfortable while getting the injection and after) and VACCINATION SITE PAIN (Injection felt painful) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-May-2021, the patient experienced DISCOMFORT (more uncomfortable while getting the injection and after) and VACCINATION SITE PAIN (Injection felt painful). At the time of the report, DISCOMFORT (more uncomfortable while getting the injection and after) and VACCINATION SITE PAIN (Injection felt painful) outcome was unknown.            No relevant concomitant medications were reported.No treatment information was provided.Action taken with mRNA-1273 in response to the events was not applicable. The patient barely felt the injection during her first dose.    This case was linked to US-MODERNATX, INC.-MOD-2021-123076, US-MODERNATX, INC.-MOD-2021-122933 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-123076:Case for mother US-MODERNATX, INC.-MOD-2021-122933:Case for husband
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination site swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of neck pain and vaccination site swelling (swelling at injection site) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 11, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced neck pain and vaccination site swelling (swelling at injection site). At the time of the report, neck pain and vaccination site swelling (swelling at injection site) outcome: unknown. No concomitant medication or treatment information provided. Action taken with mRNA-1273 in response to the event: not applicable.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Swollen tongue, Throat irritation
Clinical narrative: throat itching; lip swelling; tongue swelling; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (throat itching), LIP SWELLING (lip swelling) and SWOLLEN TONGUE (tongue swelling) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 004C21A) for COVID-19 vaccination.     No relevant medical history reported.  Concomitant products included HYDROCHLOROTHIAZIDE, AMLODIPINE, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), SIMVASTATIN, CLONAZEPAM, MELATONIN and HYDROXYCAMPTOTHECIN for an unknown indication.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced THROAT IRRITATION (throat itching), LIP SWELLING (lip swelling) and SWOLLEN TONGUE (tongue swelling). The patient was treated with LEVOCABASTINE HYDROCHLORIDE (ZYRTEC [LEVOCABASTINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, THROAT IRRITATION (throat itching), LIP SWELLING (lip swelling) and SWOLLEN TONGUE (tongue swelling) had resolved.            Concomitant medication includes multivitamin, Hepaguard
Age: 101.0
Sex: F
Vaccine: COVID19
Symptoms: Daydreaming, Pain in extremity
Clinical narrative: being out of mind for two weeks; A lot of pain and soreness in legs and feet; This spontaneous case was reported by a consumer and describes the occurrence of DAYDREAMING (being out of mind for two weeks) and PAIN IN EXTREMITY (A lot of pain and soreness in legs and feet) in a 101-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1218) for COVID-19 vaccination.     Concurrent medical conditions included Hospice care. Concomitant products included LISINOPRIL, FUROSEMIDE (LASIX [FUROSEMIDE]) and POTASSIUM for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced DAYDREAMING (being out of mind for two weeks) and PAIN IN EXTREMITY (A lot of pain and soreness in legs and feet). At the time of the report, DAYDREAMING (being out of mind for two weeks) and PAIN IN EXTREMITY (A lot of pain and soreness in legs and feet) outcome was unknown.            No treatment information was provided.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Colon injury, Influenza
Clinical narrative: Problems with their colon; Flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms) and COLON INJURY (Problems with their colon) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced INFLUENZA (Flu symptoms). On an unknown date, the patient experienced COLON INJURY (Problems with their colon). The patient was treated with PARACETAMOL, PHENIRAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (THERAFLU [PARACETAMOL;PHENIRAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]) ongoing since an unknown date for Flu, at a dose of 1 dosage form. At the time of the report, INFLUENZA (Flu symptoms) and COLON INJURY (Problems with their colon) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Significant follow up appended-Added reporter details, Patient demographics, Product details, Treatment medication, Event start date.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received dose of a vaccine from an expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose of a vaccine from an expired vial) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose of a vaccine from an expired vial). On 11-May-2021, EXPIRED PRODUCT ADMINISTERED (Patient received dose of a vaccine from an expired vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No treatment medication was reported.   This case was linked to  INC.-MOD-2021-122741,  INC.-MOD-2021-122781 (E2B Linked Report).; Sender's Comments:  MOD-2021-122781:crosslinked
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in the arm) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009C21A and 009C21A) for COVID-19 vaccination.     No medical history was reported by the reporter.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-May-2021, the patient experienced PAIN IN EXTREMITY (Soreness in the arm). On 11-May-2021, PAIN IN EXTREMITY (Soreness in the arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported No lab data was reported No treatment medication was reported   This case was linked to MOD-2021-215087 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: 1 dose event outcome updated to resolved and 2nd dose details and event also added
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Asthenia, Computerised tomogram, Fatigue, Feeling abnormal
Clinical narrative: Slept a lot; brain felt foggy; Maybe she doesn't have as much energy; Very bad headache; Churning in my stomach; tired/ fatigue/ Tiredness; extreme nausea; extreme vomiting/ Feeling like I might vomit; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy), ABDOMINAL DISCOMFORT (Churning in my stomach), ASTHENIA (Maybe she doesn't have as much energy) and NAUSEA (extreme nausea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (extreme nausea) and VOMITING (extreme vomiting/ Feeling like I might vomit). On 27-Mar-2021, the patient experienced FATIGUE (tired/ fatigue/ Tiredness). On 25-May-2021, the patient experienced ABDOMINAL DISCOMFORT (Churning in my stomach). On 27-May-2021, the patient experienced HEADACHE (Very bad headache). On an unknown date, the patient experienced SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy) and ASTHENIA (Maybe she doesn't have as much energy). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN EXTRA STRENGTH) at an unspecified dose and frequency and DOMPERIDONE (EMETROL [DOMPERIDONE]) for Adverse event, at an unspecified dose and frequency. On 27-May-2021, ABDOMINAL DISCOMFORT (Churning in my stomach), NAUSEA (extreme nausea), VOMITING (extreme vomiting/ Feeling like I might vomit), FATIGUE (tired/ fatigue/ Tiredness) and HEADACHE (Very bad headache) had resolved. At the time of the report, SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy) and ASTHENIA (Maybe she doesn't have as much energy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Computerised tomogram: excellent (normal) excellent.         No concomitant medication information were reported. The patient was still experiencing severe nausea and headaches. This same episode recurs about every 10 days to 2 weeks. The episode lasts for 3 days and the patient has been  through 10 cycles now. The patient had seen the doctor and her blood work and an abdominal CAT scan were all excellent.   On 25-May-2021, patient experienced another episode of nausea, vomiting and fatigue.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Another episode of events added. On 07-Jul-2021: Significant follow up as the same events with increased severity persists and concern about not received any additional information on side effects
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Somnolence, Vomiting
Clinical narrative: Slept a lot; brain felt foggy; Maybe she doesn't have as much energy; Very bad headache; Churning in my stomach; tired/ fatigue/ Tiredness; extreme nausea; extreme vomiting/ Feeling like I might vomit; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy), ABDOMINAL DISCOMFORT (Churning in my stomach), ASTHENIA (Maybe she doesn't have as much energy) and NAUSEA (extreme nausea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced NAUSEA (extreme nausea) and VOMITING (extreme vomiting/ Feeling like I might vomit). On 27-Mar-2021, the patient experienced FATIGUE (tired/ fatigue/ Tiredness). On 25-May-2021, the patient experienced ABDOMINAL DISCOMFORT (Churning in my stomach). On 27-May-2021, the patient experienced HEADACHE (Very bad headache). On an unknown date, the patient experienced SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy) and ASTHENIA (Maybe she doesn't have as much energy). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN EXTRA STRENGTH) at an unspecified dose and frequency and DOMPERIDONE (EMETROL [DOMPERIDONE]) for Adverse event, at an unspecified dose and frequency. On 27-May-2021, ABDOMINAL DISCOMFORT (Churning in my stomach), NAUSEA (extreme nausea), VOMITING (extreme vomiting/ Feeling like I might vomit), FATIGUE (tired/ fatigue/ Tiredness) and HEADACHE (Very bad headache) had resolved. At the time of the report, SOMNOLENCE (Slept a lot), FEELING ABNORMAL (brain felt foggy) and ASTHENIA (Maybe she doesn't have as much energy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Computerised tomogram: excellent (normal) excellent.         No concomitant medication information were reported. The patient was still experiencing severe nausea and headaches. This same episode recurs about every 10 days to 2 weeks. The episode lasts for 3 days and the patient has been  through 10 cycles now. The patient had seen the doctor and her blood work and an abdominal CAT scan were all excellent.   On 25-May-2021, patient experienced another episode of nausea, vomiting and fatigue.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Another episode of events added. On 07-Jul-2021: Significant follow up as the same events with increased severity persists and concern about not received any additional information on side effects
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: left arm hurt like someone punched my arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Allergy NOS, Polycystic ovarian syndrome and Thyroid disorder NOS. Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for Allergy NOS, LABETALOL HYDROCHLORIDE (LABETALOL [LABETALOL HYDROCHLORIDE]) and FOSINOPRIL for Hypertension, METFORMIN HYDROCHLORIDE (METFORMIN ER) for Polycystic ovarian syndrome, DULAGLUTIDE (TRULICITY) for Polycystic ovary, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 mg and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 200 mg three times a day. On 09-May-2021, PAIN IN EXTREMITY (left arm hurt like someone punched my arm) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Intermenstrual bleeding, Menstruation irregular
Clinical narrative: Menstrual period started the next day after second dose/ that the period initiated 2 weeks early; Bleeding for 5 days, then stopped; Exhaustion; Chills and exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early), INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped), FATIGUE (exhaustion) and CHILLS (chills and exhaustion) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 038B21A) for COVID-19 vaccination.     The patient's past medical history included Endometrial ablation.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced FATIGUE (exhaustion) and CHILLS (chills and exhaustion). On 06-May-2021, the patient experienced MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early) and INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped). On 11-May-2021, MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early) and INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped) had resolved. At the time of the report, FATIGUE (exhaustion) and CHILLS (chills and exhaustion) outcome was unknown.            Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: NNI
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Myalgia, Oral herpes, Oral pain, Pruritus
Clinical narrative: cold sores around mouth; blisters on lower corners of the mouth,blisters around mouth; blisters in each corner of the mouth and are a little painful; itchy blisters; slight soreness of the muscle; This spontaneous case was reported by a consumer and describes the occurrence of ORAL HERPES (cold sores around mouth), BLISTER (blisters on lower corners of the mouth,blisters around mouth), ORAL PAIN (blisters in each corner of the mouth and are a little painful), PRURITUS (itchy blisters) and MYALGIA (slight soreness of the muscle) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 immunisation.     No medical history reported.  Concomitant products included HYDROCORTISONE for an unknown indication.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ORAL HERPES (cold sores around mouth), BLISTER (blisters on lower corners of the mouth,blisters around mouth), ORAL PAIN (blisters in each corner of the mouth and are a little painful), PRURITUS (itchy blisters) and MYALGIA (slight soreness of the muscle). The patient was treated with HYDROCORTISONE for Swelling and Itching, at an unspecified dose and frequency. At the time of the report, ORAL HERPES (cold sores around mouth), BLISTER (blisters on lower corners of the mouth,blisters around mouth), ORAL PAIN (blisters in each corner of the mouth and are a little painful), PRURITUS (itchy blisters) and MYALGIA (slight soreness of the muscle) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: "it hurt like heck"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ("it hurt like heck") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced VACCINATION SITE PAIN ("it hurt like heck"). At the time of the report, VACCINATION SITE PAIN ("it hurt like heck") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment was reported   This case was linked to US-MODERNATX, INC.-MOD-2021-092573 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow up received: No significant information was reported.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092573:Case for second dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Confusional state, Memory impairment, Myalgia
Clinical narrative: Confusion at times; Forgets her words in the middle of the sentence; Soreness in right arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness in right arm), CONFUSIONAL STATE (Confusion at times) and MEMORY IMPAIRMENT (Forgets her words in the middle of the sentence) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 009C21A) for COVID-19 vaccination.     No relevant past medical history was provided.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced MYALGIA (Soreness in right arm), CONFUSIONAL STATE (Confusion at times) and MEMORY IMPAIRMENT (Forgets her words in the middle of the sentence). On 13-Apr-2021, MYALGIA (Soreness in right arm), CONFUSIONAL STATE (Confusion at times) and MEMORY IMPAIRMENT (Forgets her words in the middle of the sentence) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Patient's daughter called on behalf of her mother(patient) who has been experiencing some side effects of the Moderna COVID-19 Vaccinations.  Patient had some soreness in arms, appears confused at times, and stops in the middle of her sentence and forgets what she is saying. Patient received the first dose of the Moderna COVID-19 Vaccination in the right arm muscle; with unknown Expiration date.  Patient experiences some soreness in her right arm, confusion at times, and forgets her words in the middle of her sentences, however it all resolved the next day, 13Apr2021.   The second dose of the Moderna COVID-19 Vaccine was given on 11May2021, in her left arm muscle; Lot number:  009C21A; unknown Expiration date.  Patient experience soreness in her left arm and is more confused this time and forgets more and stops in the middle of her sentence when she is saying something and has not gone away.  Daughter is bringing her mother (patient) to her health care provider today, 12May2021.  Daughter's mother (patient) was present while daughter was speaking to Agent and gave consent for follow up with patient's health care provider and Safety.  Preferred communication is phone number
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Vaccination site pain
Clinical narrative: Shingles; Little soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DOFETILIDE, APIXABAN (ELIQUIS), LOSARTAN and METOPROLOL for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, the patient experienced HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm). The patient was treated with VALACYCLOVIR [VALACICLOVIR] for Shingles, at a dose of 1 gram and TRIAMCINOLONE for Shingles, at a dose of 0.1 %. At the time of the report, HERPES ZOSTER (Shingles) and VACCINATION SITE PAIN (Little soreness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 14 May 2021 contains no new information. On 15-Jul-2021: Follow-up information received on 15 Jul 2021 contains Non-significant information.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Decreased appetite, Electrocardiogram, Feeling abnormal, Malaise
Clinical narrative: Rapid Heart Beat; Loss of appetite; Felt drugged up; Fuzzy in head \ Feels Spacy in her head; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Rapid Heart Beat), FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head). On 05-May-2021, the patient experienced PALPITATIONS (Rapid Heart Beat), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up). At the time of the report, PALPITATIONS (Rapid Heart Beat), FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Blood pressure measurement: normal (normal) slightly elevated. On 05-May-2021, Electrocardiogram: normal (normal) Electrocardiogram normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment medicines included, Blood pressure medications to control fast heart beat.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Rapid Heart Beat; Loss of appetite; Felt drugged up; Fuzzy in head \ Feels Spacy in her head; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Rapid Heart Beat), FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head). On 05-May-2021, the patient experienced PALPITATIONS (Rapid Heart Beat), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up). At the time of the report, PALPITATIONS (Rapid Heart Beat), FEELING ABNORMAL (Fuzzy in head \ Feels Spacy in her head), DECREASED APPETITE (Loss of appetite) and MALAISE (Felt drugged up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Blood pressure measurement: normal (normal) slightly elevated. On 05-May-2021, Electrocardiogram: normal (normal) Electrocardiogram normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment medicines included, Blood pressure medications to control fast heart beat.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort
Clinical narrative: Arm was bad; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm was bad) and FATIGUE (Very tired) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Headache. Concurrent medical conditions included Cholesterol, Penicillin allergy, Allergy to vaccine (Tetanus shot.) and Ragweed allergy. Concomitant products included ATORVASTATIN for Cholesterol, ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) for Headache, VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Arm was bad) and FATIGUE (Very tired). At the time of the report, LIMB DISCOMFORT (Arm was bad) and FATIGUE (Very tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Follow up received contain additional second dose events and associated lab data added; no significant information for the first dose case On 02-Jul-2021: Follow-up received on 02-JUL-2021, contains patient demographic details, patient medical history allergic information, concomitant medication information and first dose date
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Malaise, Pain, Pruritus
Clinical narrative: pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate; Breast pain; Twingy; "itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection; Armpit pain; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cardiovascular disease, unspecified. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Cardiovascular disease, unspecified.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain). At the time of the report, PAIN (pain intensified from itchy to a "persistent twingy pain" that ranges rom mild to moderate), BREAST PAIN (Breast pain), MALAISE (Twingy), PRURITUS ("itchy odd sensation" on the left side (side of injection) of the "armpit" that radiates to the breast area that began a week after injection) and AXILLARY PAIN (Armpit pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: normal (normal) No abnormalities were found.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked toMOD-2021-123400 (E2B Linked Report).; Sender's Comments:  MOD-2021-123400:dose 2